NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/06/2023
Back to search
Official data from USPTO
NEURAMIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
06/06/2023
Trademark type
Combined
Nice classes
5, 10
Filing date
04/08/2022
Registration date
06/06/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/06/2023
Last transaction
06/06/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
Chungcheongbuk-do, KR
Examiner
BRYANT, ALEXANDRIA
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "NEURAMIS" in a stylized form with the capital letter "N" in "NEURAMIS" featuring gradational shading.
Holders and representatives
Holders
Medytox Inc.
Representatives
Mark J. Liss LEYDIG, VOIT & MAYER, LTD.
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalshyaluronate acid and modified hyaluronate acid for use as a soft tissue filler for treatment of damaged tissue; specialized medical capsulesself-contained ampules sold filled with pharmaceuticals for use in dispensing the same in the nature of prepackaged hyaluronic acid and derivatives thereof alonein combination with other polysaccharide for pharmaceutical purposes in particular starchcellulose esterswith and without lidocaine; dermal tissue filler kits comprising hyaluronic acid gel sold in pre-filled syringes for injecting under the skin for use in reducing and eliminating fine skin lines and wrinklesfilling scarscontouring the lips and face; pharmaceutical preparationshyaluronic acid and modified hyaluronic acidits derivatives and saltsbiological skin tissue for implantationall sold in pre-filled syringes for eliminating fine skin lines and wrinkles
Class 10
Dermatological implants for medical use consisting of artificial materials in the nature of visco-supplementation substances for filling skin wrinkles and increasing skin volume
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/21/2023
PUBO
PUBLISHED FOR OPPOSITION
03/21/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/09/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/05/2023
GNRT
NON-FINAL ACTION E-MAILED
01/05/2023
CNRT
NON-FINAL ACTION WRITTEN
01/05/2023
DOCK
ASSIGNED TO EXAMINER
12/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/13/2022
NWAP
NEW APPLICATION ENTERED
04/12/2022
Continuous trademark protection
Get notified about every new filing that threatens NEURAMIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.